Kijima T - Search Results

1

Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.

Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A. Osa A, et al. Among authors: kijima t. JCI Insight. 2018 Oct 4;3(19):e59125. doi: 10.1172/jci.insight.59125. JCI Insight. 2018. PMID: 30282824 Free PMC article.

2

A 100-kDa protein tyrosine phosphorylation is concurrent with beta 1 integrin-mediated morphological differentiation in neuroblastoma and small cell lung cancer cells.

Tachibana I, Mori M, Tanio Y, Hosoe S, Sakuma T, Osaki T, Ueno K, Kumagai T, Kijima T, Kishimoto T. Tachibana I, et al. Among authors: kijima t. Exp Cell Res. 1996 Sep 15;227(2):230-9. doi: 10.1006/excr.1996.0272. Exp Cell Res. 1996. PMID: 8831561

3

Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.

Funakoshi T, Tachibana I, Hoshida Y, Kimura H, Takeda Y, Kijima T, Nishino K, Goto H, Yoneda T, Kumagai T, Osaki T, Hayashi S, Aozasa K, Kawase I. Funakoshi T, et al. Among authors: kijima t. Oncogene. 2003 Feb 6;22(5):674-87. doi: 10.1038/sj.onc.1206106. Oncogene. 2003. PMID: 12569360

4

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

Namba Y, Kijima T, Yokota S, Niinaka M, Kawamura S, Iwasaki T, Takeda Y, Kimura H, Okada T, Yamaguchi T, Nakagawa M, Okumura Y, Maeda H, Ito M. Namba Y, et al. Among authors: kijima t. Clin Lung Cancer. 2004 Sep;6(2):123-8. doi: 10.3816/CLC.2004.n.026. Clin Lung Cancer. 2004. PMID: 15476598 Review.

5

Anti-fibrotic effects of theophylline on lung fibroblasts.

Yano Y, Yoshida M, Hoshino S, Inoue K, Kida H, Yanagita M, Takimoto T, Hirata H, Kijima T, Kumagai T, Osaki T, Tachibana I, Kawase I. Yano Y, et al. Among authors: kijima t. Biochem Biophys Res Commun. 2006 Mar 17;341(3):684-90. doi: 10.1016/j.bbrc.2006.01.018. Epub 2006 Jan 18. Biochem Biophys Res Commun. 2006. PMID: 16430859

6

The gefitinib-sensitizing mutant epidermal growth factor receptor enables transformation of a mouse fibroblast cell line.

Nagatomo I, Kumagai T, Yamadori T, Furukawa M, Takahashi R, Yoneda T, Ogata Y, Saito Y, Inoue K, Yano Y, Kijima T, Yoshida M, Osaki T, Tachibana I, Greene MI, Kawase I. Nagatomo I, et al. Among authors: kijima t. DNA Cell Biol. 2006 Apr;25(4):246-51. doi: 10.1089/dna.2006.25.246. DNA Cell Biol. 2006. PMID: 16629597

7

[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].

Osaki T, Takimoto T, Furukawa M, Inoue M, Okumura M, Niju T, Kijima T, Kumagai T, Yoshida M, Tachibana I, Kawase I. Osaki T, et al. Among authors: kijima t. Gan To Kagaku Ryoho. 2006 Aug;33(8):1119-23. Gan To Kagaku Ryoho. 2006. PMID: 16912531 Japanese.

8

The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivo.

Yoneda T, Kumagai T, Nagatomo I, Furukawa M, Yamane H, Hoshino S, Mori M, Takeda Y, Horai T, Nishida S, Watanabe D, Kijima T, Yoshida M, Osaki T, Tachibana I, Greene MI, Kawase I. Yoneda T, et al. Among authors: kijima t. DNA Cell Biol. 2006 Sep;25(9):530-40. doi: 10.1089/dna.2006.25.530. DNA Cell Biol. 2006. PMID: 16989576

9

Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells.

Saito Y, Tachibana I, Takeda Y, Yamane H, He P, Suzuki M, Minami S, Kijima T, Yoshida M, Kumagai T, Osaki T, Kawase I. Saito Y, et al. Among authors: kijima t. Cancer Res. 2006 Oct 1;66(19):9557-65. doi: 10.1158/0008-5472.CAN-06-1131. Cancer Res. 2006. PMID: 17018612

10

Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation.

Ogata Y, Osaki T, Naka T, Iwahori K, Furukawa M, Nagatomo I, Kijima T, Kumagai T, Yoshida M, Tachibana I, Kawase I. Ogata Y, et al. Among authors: kijima t. Neoplasia. 2006 Oct;8(10):817-25. doi: 10.1593/neo.06409. Neoplasia. 2006. PMID: 17032498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page